BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26890126)

  • 21. Genomic data integration in chronic lymphocytic leukemia.
    Fernández-Martínez JL; deAndrés-Galiana EJ; Sonis ST
    J Gene Med; 2017 Jan; 19(1-2):. PubMed ID: 27928896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics of high-risk chronic lymphocytic leukemia.
    Rossi D; Gaidano G
    Expert Rev Hematol; 2012 Dec; 5(6):593-602. PubMed ID: 23216591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
    Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
    Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL).
    Zenz T; Fröhling S; Mertens D; Döhner H; Stilgenbauer S
    Best Pract Res Clin Haematol; 2010 Mar; 23(1):71-84. PubMed ID: 20620972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of genetics in chronic lymphocytic leukemia.
    Zenz T; Mertens D; Döhner H; Stilgenbauer S
    Blood Rev; 2011 May; 25(3):131-7. PubMed ID: 21435757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene mutations in chronic lymphocytic leukemia.
    Amin NA; Malek SN
    Semin Oncol; 2016 Apr; 43(2):215-21. PubMed ID: 27040699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis, Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Exciting Times.
    Hallek M
    Oncol Res Treat; 2016; 39(1-2):8. PubMed ID: 26889878
    [No Abstract]   [Full Text] [Related]  

  • 29. Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years.
    Kruzova L; Schneiderova P; Holzerova M; Vatolikova M; Divoka M; Turcsanyi P; Urbanova R; Kudelka M; Radvansky M; Kriegova E; Papajik T; Urbankova H
    Leuk Res; 2019 Oct; 85():106218. PubMed ID: 31476701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in chronic lymphocytic leukemia-what do we need to know?
    Cramer P; Hallek M
    Nat Rev Clin Oncol; 2011 Jan; 8(1):38-47. PubMed ID: 20956983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing Molecular Signatures for Chronic Lymphocytic Leukemia.
    Cornet E; Debliquis A; Rimelen V; Civic N; Docquier M; Troussard X; Drénou B; Matthes T
    PLoS One; 2015; 10(6):e0128990. PubMed ID: 26046539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
    Vollbrecht C; Mairinger FD; Koitzsch U; Peifer M; Koenig K; Heukamp LC; Crispatzu G; Wilden L; Kreuzer KA; Hallek M; Odenthal M; Herling CD; Buettner R
    PLoS One; 2015; 10(6):e0129544. PubMed ID: 26053404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.
    Morabito F; Cutrona G; Mosca L; D'Anca M; Matis S; Gentile M; Vigna E; Colombo M; Recchia AG; Bossio S; De Stefano L; Maura F; Manzoni M; Ilariucci F; Consoli U; Vincelli I; Musolino C; Cortelezzi A; Molica S; Ferrarini M; Neri A
    Leuk Res; 2015 Aug; 39(8):840-5. PubMed ID: 26038121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.
    Tausch E; Beck P; Schlenk RF; Jebaraj BJ; Dolnik A; Yosifov DY; Hillmen P; Offner F; Janssens A; Babu GK; Grosicki S; Mayer J; Panagiotidis P; McKeown A; Gupta IV; Skorupa A; Pallaud C; Bullinger L; Mertens D; Döhner H; Stilgenbauer S
    Haematologica; 2020 Oct; 105(10):2440-2447. PubMed ID: 33054084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
    Baumann T; Delgado J; Santacruz R; Martínez-Trillos A; Rozman M; Aymerich M; López C; Costa D; Carrió A; Villamor N; Montserrat E
    Br J Haematol; 2016 Jan; 172(1):48-55. PubMed ID: 26559905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of the molecular genetics of chronic lymphocytic leukemia.
    Foà R; Del Giudice I; Guarini A; Rossi D; Gaidano G
    Haematologica; 2013 May; 98(5):675-85. PubMed ID: 23633543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
    Parikh SA; Shanafelt TD
    Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic lymphocytic leukemia. Treatment and genetic risk profile].
    Stilgenbauer S; Hallek M
    Internist (Berl); 2013 Feb; 54(2):164, 166-70. PubMed ID: 23371259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
    Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
    J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments.
    Hu B; Patel KP; Chen HC; Wang X; Wang F; Luthra R; Routbort MJ; Kanagal-Shamanna R; Medeiros LJ; Yin CC; Zuo Z; Ok CY; Loghavi S; Tang G; Tambaro FP; Thompson P; Burger J; Jain N; Ferrajoli A; Bose P; Estrov Z; Keating MJ; Wierda WG
    Br J Haematol; 2019 Jun; 185(5):852-864. PubMed ID: 30924136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.